Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
International Journal of Hematology
Taiki AndoYokohama Cooperative Study Group for Hematology (YACHT)
Clinical Lymphoma, Myeloma & Leukemia
Prajwal DhakalVijaya Raj Bhatt
Cancer
Naveen PemmarajuJorge Cortes
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ingiridur Skírnisdóttir, Bengt Sorbe
Gynecology and Minimally Invasive Therapy
Akiko OtakeKazusige Adachi